INDIANAPOLIS - Indianapolis-based Eli Lilly and Company is restructuring part of its drug product manufacturing. As a result, up to 100 jobs in central Indiana will be cut. However, those jobs will not be entirely lost, officials said Friday.
Patent expirations were the reason behind the cuts and the changes will take place over the next several years.
Company officials said while jobs will be lost with certain products in the pipeline, there will be new opportunities within the company for new products coming soon.
"This transition will take several years to implement. Employees affected by this plan will have opportunities to move elsewhere within manufacturing, such as our growing insulin and biotechnology areas. As previously announced, Lilly continues to advance insulin-related investments in Indianapolis totaling nearly half a billion dollars to expand insulin active ingredient and drug product manufacturing capacity," a spokesman said in a statement.
Watch RTV6 and refresh this page for updates.
Memorial Day: Summer warmth and sunshine
Happy Memorial Day and thank you to all who have or are serving our country.
Looking ahead to 100 more years of the Indy 500
Ray Harroun never could have envisioned the speed, science and styling behind the cars on the starting grid for the 100th Indy 500, not when…
The 100th Running of the Indy 500 in photos
PHOTOS: Unbelievable win for the rookie Rossi
PHOTOS: Famous faces at the Indy 500
Celebrities came to celebrate the 100th running of the Indianapolis 500.